illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. NexImmune
Company logo

NexImmune | Sustainability Performance

https://www.neximmune.com

Develops T-cell-based immunotherapies for cancer and other diseases.

2011

United States

1-10 employees

Biotechnology

$100K - 500K in revenue

N/A in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#7264
Overallⓘ
#1550
in United Statesⓘ
#141
in Biotechnologyⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

54 out of 245

Overview
Environmental
Nature and biodiversity
Social
Externalities
Governance
SDG Impact

View similiar companies

Company logo
Arcturus Therapeutics

United States, Health Care, Biotechnology

Company logo
Encompass health

United States, Health Care, Hospital & Health Care

Company logo
Biomarin Pharmaceutical

United States, Health Care, Biotechnology

Externalities ⓘThe monetized estimate of environmental and social impacts caused by an organization that are not reflected in its financial accounts.
10.4K$, 2023
Critical

Reporting

sustainability report symbol

Sustainability Report

 Available
image report
Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

    Available in
    Scale package

    Access
  • Email
  • Email